Obarorakpor, NyerhovwoPatel, DeepBoyarov, ReniAmarsaikhan, NansalmaaCepeda, Joseph RayEastes, DoreenRobertson, SylviaJohnson, TravisYang, KaiTang, QizhiZhang, Li2024-06-242024-06-242024-03-07Obarorakpor N, Patel D, Boyarov R, et al. Corrigendum: Regulatory T cells targeting a pathogenic MHC class II: insulin peptide epitope postpone spontaneous autoimmune diabetes. Front Immunol. 2024;15:1391518. Published 2024 Mar 7. doi:10.3389/fimmu.2024.1391518https://hdl.handle.net/1805/41824In the published article, there was an error in the Funding statement. Grant “JDRF 2-SRA-2018-648-S-B” grant was missing in the statement. The correct Funding statement appears below. Funding This study was supported by grants from NIH R03AI139811-01A1, DoD W81XWH2210087, JDRF 2-SRA-2018-648-S-B, and a Pilot and Feasibility Award from the CDMD NIH/NIDDK Grant Number P30 DK097512 (to LZ). The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.en-USAttribution 4.0 InternationalType 1 diabetesRegulatory T cellChimeric antigen receptorAntigen specific immunotherapyMHC II/Insulin complexMonoclonal antibodyArticle